A new way to keep the immune system engaged in its fight against skin cancer has been identified by recent research. The research team is planning to test the approach in phase 1 clinical trial. Unmasking melanoma cells to immune cells enables the immune system to mount a direct attack while also enhancing the function of current immunotherapies such as pembrolizumab and nivolumab.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer